Synthetic Pathways for Drug Discovery

Synthetic pathways for drug discovery emphasize efficiency, molecular diversity, and precise functionalization to support the development of therapeutics with optimal biological activity. Advances in medicinal chemistry, late-stage functionalization, stereocontrolled synthesis, and fragment-based approaches accelerate the creation of candidate molecules. Innovations in C–H activation, photoredox catalysis, and biocatalytic transformations introduce new ways to incorporate pharmacophores. Modular synthesis, rapid analog generation, and predictive digital tools streamline lead-optimization workflows. Focus on green methodologies improves sustainability without sacrificing molecular complexity. These evolving strategies enable chemists to access novel scaffolds, enhance drug-like properties, and shorten development timelines for emerging treatments.

    Related Conference of Synthetic Pathways for Drug Discovery

    November 16-17, 2026

    11th Global Summit on Midwifery and Womens Health

    Tokyo, Japan
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands
    January 18-19, 2027

    44th International Conference on Womens Health

    Bangkok, Thailand
    January 18-19, 2027

    10th World Congress on PCOS and Reproductive Healthcare

    Bangkok, Thailand
    February 01-02, 2027

    9th International Conference on Digital Health

    London, UK
    February 15-16, 2027

    23rd World Congress on Healthcare & Technologies

    Paris, France
    May 17-18, 2027

    38th European Heart and Heart Failure Congress

    Paris, France
    July 26-27, 2027

    5th Global Conference on Aging and Gerontology

    Paris, France
    August 24-25, 2027

    23rd Global Biomarkers and Clinical Research Summit

    Paris, France

    Synthetic Pathways for Drug Discovery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in